Don't miss out on the latest business and technology news for chemical engineers, featuring select items in relation to Food, Pharmaceuticals & Bioengineering
RD raises concerns about food sensitivity tests
An increase in food sensitivity tests has led to longer lists of specific foods and ingredients people say they cannot eat, raising concerns about what type of diet they can tolerate, said registered dietitian Tamara Duker Freuman. The real issue may be the tests, Freuman said, which may not be scientifically proven and many of which even measure an antibody that actually is a sign of food tolerance.
Analysis links opioid Rx volume to payments from drugmakers
An analysis of data from two federal government databases showed 54% of US physicians who prescribed opioids to Medicare patients from 2014 to 2015 received payments from opioid makers. Physicians who wrote the most opioid prescriptions were most likely to receive payments from opioid manufacturers, and they also received more money than doctors who wrote fewer opioid prescriptions.
Salmonella scare prompts recall of Starwest's organic cardamom
A recall was initiated by Starwest Botanicals for whole, green Starwest Botanicals Organic Cardamom Pods because they could be contaminated with salmonella. The recalled pods, which are in 1-pound Mylar bags and in bulk packages, bear the UPC numbers 7-6796302528-9 and 7-6796302527-2, lot numbers 75593 and 90186-00, respectively, and were sold nationwide through mail order, online and at Starwest Botanicals stores.
FDA approves Medtronic's Guardian Connect CGM
Medtronic's Guardian Connect continuous glucose monitoring system was approved by the FDA for diabetes patients ages 14 to 75 after a clinical trial showed that it accurately alerted patients about 98.5% of hypoglycemic events. The device uses an advanced glucose sensor to alert patients of potentially low or high glucose events and enables caregivers to monitor blood glucose levels of users in real time.
Syngenta settles biotech corn strain litigation for $1.5B
Syngenta will pay $1.5 billion to settle claims that its biotech corn seed commercialization affected US corn exports to China. The settlement agreement is expected to provide fair compensation for damages to more than 600,000 corn producers, ethanol plants and grain handling facilities who sold corn priced after Sept. 15, 2013.
- Log in to post comments